Close

Canaccord Genuity Downgrades HealthStream (HSTM) to Hold

Go back to Canaccord Genuity Downgrades HealthStream (HSTM) to Hold

Needham & Company Cuts Price Target on HealthStream (HSTM) to $28 Following 3Q

November 4, 2016 7:20 AM EDT

Needham & Company maintained a Buy rating on HealthStream (NASDAQ: HSTM), and cut the price target to $28.00 (from $32.00), following the company's 3Q earnings report. HSTMs workforce solutions segment grew 4.6% Y/Y, driven by elevated demand for the resuscitation suite which continues to exceed internal expectations. Revenues were... More

HealthStream (HSTM) Misses Q3 EPS by 3c

November 2, 2016 4:45 PM EDT

HealthStream (NASDAQ: HSTM) reported Q3 EPS of $0.04, $0.03 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $58.4 million versus the consensus estimate of $58.7 million.

For earnings history and earnings-related data on HealthStream (HSTM) click here.

... More